Neuropeptide sleep research compound (unapproved)
Delta sleep-inducing peptide
A neuropeptide historically studied for sleep architecture and stress modulation; human evidence remains inconsistent.
- Evidence:
- Limited human evidence
- Status:
- Research-stage
- Reviewed:
- 2026-08-03
Also known as: Delta sleep-inducing peptide
What is Delta sleep-inducing peptide?
A neuropeptide historically studied for sleep architecture and stress modulation; human evidence remains inconsistent.
This profile is educational. It organizes publicly discussed research context for Delta sleep-inducing peptide and related naming aliases — it is not a treatment guide.
Proposed mechanism
Proposed modulation of sleep-wake regulatory circuits and stress response; exact receptor mechanism not fully established.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Limited human evidence
Preclinical evidence grade: Early-stage human research
DSIP was discovered for delta-wave sleep promotion in rabbits. Human studies show inconsistent sleep effects. Russian clinical use reported but Western replication limited. Often sold in research peptide markets without robust evidence. Nasal bioavailability for many peptides is poorly characterized.
Key uncertainties
- Reproducible sleep benefits in humans
- Mechanism of action
Research areas being studied
- Sleep architecture
- Stress response
- Insomnia research
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Morning grogginess reported anecdotally
- Systematic AE data lacking
Additional risks & considerations
- Inconsistent efficacy
- Unregulated products
- Unknown long-term safety
Regulatory status
Research-stage
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Delta sleep-inducing peptide?
A neuropeptide historically studied for sleep architecture and stress modulation; human evidence remains inconsistent.
How does Delta sleep-inducing peptide work (proposed mechanism)?
Proposed modulation of sleep-wake regulatory circuits and stress response; exact receptor mechanism not fully established.
What is Delta sleep-inducing peptide being researched for?
Delta sleep-inducing peptide has been discussed in research contexts including: Sleep architecture, Stress response, Insomnia research.
What does current evidence say about Delta sleep-inducing peptide?
Limited human evidence. DSIP was discovered for delta-wave sleep promotion in rabbits. Human studies show inconsistent sleep effects. Russian clinical use reported but Western replication limited. Often sold in research peptide markets without robust evidence. Nasal bioavailability for many peptides is poorly characterized.
What safety considerations are noted for Delta sleep-inducing peptide?
Reported or discussed considerations include: Morning grogginess reported anecdotally; Systematic AE data lacking; Inconsistent efficacy; Unregulated products; Unknown long-term safety. This is educational information, not medical advice.
References & sources
- Graf MV et al. (1984). Delta sleep-inducing peptide: historical and current research — Peptides. Evidence type: review.
Prefer interactive tools? Open the PepGuide library entry for Delta sleep-inducing peptide or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.